USANA Announces Record Third Quarter 2012 Results
SALT LAKE CITY, Oct 23, 2012 -- USANA Health Sciences, Inc. announced record financial results for its fiscal third quarter ended September 29, 2012.
Net sales for the third quarter of 2012 increased by 15.1% to $165.2 million, compared with $143.5 million in the prior-year period. The growth in net sales was driven by increases in both the Company's Asia Pacific and North America/Europe regions. Changes in currency exchange rates reduced net sales by nearly $1.0 million.
Net earnings for the third quarter increased to $17.5 million, an increase of 41.2%, compared with the prior-year period. This increase was due primarily to higher net sales, lower relative Associate incentive expense, and a meaningfully lower effective tax rate of 28.2% for the quarter. Earnings per share for the quarter increased by 45.7% to $1.18, compared with $0.81 in the third quarter of the prior year. This improvement in earnings per share can be attributed to higher net earnings and a lower number of diluted shares outstanding, which resulted from the Company's share repurchases over the last 12 months. Total diluted common shares outstanding as of September 29, 2012 were 14,884, as compared with 15,205 as of October 1, 2011.
"We believe USANA's exceptional results this quarter are largely due to the strategies we set into place during 2011 and the first part of 2012, which have combined to generate strong momentum for USANA," said Mr. Dave Wentz, Chief Executive Officer. "A highlight of the quarter was our 20th anniversary celebration at our International Convention in Salt Lake City, where we had record attendance and record sales. A significant part of our convention was the unveiling of our personalization strategy, which focuses on our customers and their experience with us. As part of this strategy, we announced MyHealthPak's availability in our Asia Pacific region and the launch of new tools and applications designed to help our Associates customize USANA's products for their customers. Personalization and customization are key components of our long-term strategy to grow our business and deliver value to both our customers and shareholders."
The Company provided the following updated financial outlook for 2012:
-- Consolidated net sales approaching $645 million, versus the previous outlook of between $630 million and $640 million.
-- Earnings per share between $4.35 and $4.40, versus the previous outlook of between $4.10 and $4.20.
Chief Financial Officer Doug Hekking commented, "In light of our strong third-quarter performance, and the current momentum we are seeing in the business, we are updating our financial outlook for the remainder of the year. Actual results and our updated forecast for the year would make 2012 USANA's tenth consecutive year of record sales."
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, October 24, 2012 at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA's website.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
Related News
-
USANA Health Names Kevin Guest CEO
November 24, 2016 -- USANA Health Sciences, Inc., a manufacturer of nutritional supplements, healthy foods and personal care products, announced Wednesday the appointment of current Co-CEO, Kevin Guest, as CEO of the company, as Dave Wentz has made the personal decision to step down as Co-CEO and a ... Read More...USANA Receives Seal of Approval for Joint Health Supplement
SALT LAKE CITY, June 2, 2016 -- Creating products aimed to improve the health and wellness of the world is the mantra of USANA Health Sciences - and having those products contain pure ingredients with accurate labels is equally important. Which is why USANA considers a seal of approval from third-pa... Read More...USANA Receives 5 Best of State Awards
SALT LAKE CITY, May 11, 2015 -- To be considered the best takes years of hard work and dedication. Remaining the best is even more challenging. Yet USANA Health Sciences continues to show its competitors why it is an industry leader, claiming five Best of State medals for its innovative science and ... Read More...USANA Recognized for Ethical Business Practices
October 31, 2014 -- FOR the fifth consecutive year, USANA Health Sciences has been recognized as one of 52 dedicated Direct Selling Association (DSA) member companies to take part in the 2014 DSA Code of Ethics Communication Initiative. While participation in the program is optional for DSA member c... Read More...
